Cargando…

Prevention of HBV Recurrence after Liver Transplant: A Review

Globally, hepatitis B virus (HBV) infection is recognized as a major risk factor for the development of hepatocellular carcinoma, and HBV-induced liver failure is one of the leading indications for liver transplantation. Until about two decades ago, liver transplantation in patients with chronic HBV...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nasir, Myra, Wu, George Y.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	XIA & HE Publishing Inc. 2020
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7438351/ https://www.ncbi.nlm.nih.gov/pubmed/32832395 http://dx.doi.org/10.14218/JCTH.2020.00003

Ejemplares similares

HEV and HBV Dual Infection: A Review
por: Nasir, Myra, et al.
Publicado: (2020)

The Role of Antiviral Prophylaxis in Preventing HBV and HDV Recurrence in the Setting of Liver Transplantation
por: Battistella, Sara, et al.
Publicado: (2023)

Hyperimmune anti-HBs plasma as alternative to commercial immunoglobulins for prevention of HBV recurrence after liver transplantation
por: Bihl, Florian, et al.
Publicado: (2010)

Management of HBV Infection in Liver Transplantation Patients
por: Vierling, John M.
Publicado: (2005)

Prevention and Treatment of Recurrent Hepatitis B after Liver Transplantation
por: Maiwall, Rakhi, et al.
Publicado: (2016)

Association of interleukin 18 gene promoter polymorphisms with HBV recurrence after liver transplantation in Han Chinese population
por: Wu, Liming, et al.
Publicado: (2011)

Preventing Tumour Recurrence after Liver Transplantation: The Role of Machine Perfusion
por: Boteon, Yuri, et al.
Publicado: (2020)

Tenofovir versus entecavir on decreasing risk of HBV-related hepatocellular carcinoma recurrence after liver transplantation
por: Yang, Jianming, et al.
Publicado: (2023)

Early intrahepatic recurrence of HBV infection in liver transplant recipients despite antiviral prophylaxis
por: Villeret, François, et al.
Publicado: (2023)

Genetic Variations in Plasma Circulating DNA of HBV-Related Hepatocellular Carcinoma Patients Predict Recurrence after Liver Transplantation
por: Hu, Jie, et al.
Publicado: (2011)

Reestablishment of Active Immunity against HBV Graft Reinfection after Liver Transplantation for HBV-Related End Stage Liver Disease
por: Lu, Shi-Chun, et al.
Publicado: (2014)

A Scoring Model Based on Neutrophil to Lymphocyte Ratio Predicts Recurrence of HBV-Associated Hepatocellular Carcinoma after Liver Transplantation
por: Wang, Guo-Ying, et al.
Publicado: (2011)

Identification of Histone Deacetylase 3 as a Biomarker for Tumor Recurrence Following Liver Transplantation in HBV-Associated Hepatocellular Carcinoma
por: Wu, Li-Ming, et al.
Publicado: (2010)

Can hepatocellular carcinoma recurrence be prevented after liver transplantation?
por: Kim, Jong Man
Publicado: (2021)

Recurrence of hepatitis C after liver transplantation
por: Vinaixa, Carmen, et al.
Publicado: (2013)

High pretransplant HBV level predicts HBV reactivation after kidney transplantation in HBV infected recipients
por: Kim, Jong Man, et al.
Publicado: (2014)

Retraction: Genetic Variations in Plasma Circulating DNA of HBV-Related Hepatocellular Carcinoma Patients Predict Recurrence after Liver Transplantation
Publicado: (2019)

Management of Hepatocellular Carcinoma Recurrence after Liver Transplantation
por: Pelizzaro, Filippo, et al.
Publicado: (2021)

Retraction: A Scoring Model Based on Neutrophil to Lymphocyte Ratio Predicts Recurrence of HBV-Associated Hepatocellular Carcinoma after Liver Transplantation
Publicado: (2019)

Prediction models of hepatocellular carcinoma recurrence after liver transplantation: A comprehensive review
por: Kim, Sang Jin, et al.
Publicado: (2022)

Prevention and treatment of recurrent Hepatitis B after liver transplantation: the current role of nucleoside and nucleotide analogues
por: Schreibman, Ian R, et al.
Publicado: (2006)

Recurrence of autoimmune liver diseases after liver transplantation: clinical aspects
por: Cholongitas, Evangelos, et al.
Publicado: (2012)

Discontinuation of Passive Immunization Is Safe after Liver Transplantation for Combined HBV/HDV Infection
por: Ossami Saidy, Ramin Raul, et al.
Publicado: (2021)

Imaging of hepatocellular carcinoma recurrence after liver transplantation
por: Mamone, Giuseppe, et al.
Publicado: (2023)

New Insights in Recurrent HCV Infection after Liver Transplantation
por: Hsu, Shih-Hsien, et al.
Publicado: (2013)

Late Recurrence of Hepatocellular Carcinoma after Liver Transplantation
por: Chok, Kenneth S. H., et al.
Publicado: (2011)

Incidence, risk factors, and clinical outcomes of HBV reactivation in non-liver solid organ transplant recipients with resolved HBV infection: A systematic review and meta-analysis
por: Yin, Saifu, et al.
Publicado: (2023)

Serum biomarkers and risk of hepatocellular carcinoma recurrence after liver transplantation
por: Citores, Maria J, et al.
Publicado: (2019)

Preoperative risk stratification for early recurrence of HBV-related hepatocellular carcinoma after deceased donor liver transplantation: a five-eight model development and validation
por: Al-Ameri, Abdulahad Abdulrab Mohammed, et al.
Publicado: (2019)

Hepatitis C Recurrence after Orthotopic Liver Transplantation: Mechanisms and Management
por: Kakati, Bobby, et al.
Publicado: (2014)

Cancer immunotherapy in patients with new or recurrent malignancies after liver transplantation
por: Liu, Mengqi, et al.
Publicado: (2017)

Retraction: Identification of Histone Deacetylase 3 as a Biomarker for Tumor Recurrence Following Liver Transplantation in HBV-Associated Hepatocellular Carcinoma
Publicado: (2019)

Clinical and Histological Long-Term Follow-Up of De Novo HBV-Infection after Liver Transplantation
por: Ossami Saidy, Ramin Raul, et al.
Publicado: (2021)

Review of Serum Biomarkers and Models Derived from Them in HBV-Related Liver Diseases
por: Wu, JianPing, et al.
Publicado: (2020)

HBV Reactivation in Patients Undergoing Hematopoietic Stem Cell Transplantation: A Narrative Review
por: Gentile, Giuseppe, et al.
Publicado: (2019)

Beneficial role of bioactive lipids in the pathobiology, prevention, and management of HBV, HCV and alcoholic hepatitis, NAFLD, and liver cirrhosis: A review
por: Das, Undurti N.
Publicado: (2018)

Mitochondria and Cancer Recurrence after Liver Transplantation—What Is the Benefit of Machine Perfusion?
por: Parente, Alessandro, et al.
Publicado: (2022)

Immune microenvironment and therapeutic progress of recurrent hepatocellular carcinoma after liver transplantation
por: Jin, Xin, et al.
Publicado: (2022)

Characterization of HBV integration patterns and timing in liver cancer and HBV-infected livers
por: Furuta, Mayuko, et al.
Publicado: (2018)

Rituximab Induction to Prevent the Recurrence of PSC After Liver Transplantation—The Lessons Learned From ABO-Incompatible Living Donor Liver Transplantation
por: Yamada, Yohei, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_lg7e770279sej6384qmih01vgp